🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well nemtabrutinib in combination with pembro...
Status
Recruiting
Location
Roswell Park Cancer Institute
Start Date
2026-08-15
Trial ID
NCT06863402
This phase II trial studies how well the addition of nemtabrutinib to lisoc...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-09-01
Trial ID
NCT07194980
Treatments Being Tested
This phase II trial tests how well nemtabrutinib works with rituximab for t...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-01-22
Trial ID
NCT06572618
This phase II trial tests the effect of nemtabrutinib in combination with b...
Status
Recruiting
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2026-07-31
Trial ID
NCT07673367
Treatments Being Tested
This study aims to evaluate the safety, tolerability, pharmacodynamic, and ...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital ( Site 0140)
Start Date
2017-06-26
Trial ID
NCT03162536
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of zilov...
Status
Active Not Recruiting
Location
Alaska Oncology and Hematology ( Site 0037)
Start Date
2022-07-21
Trial ID
NCT05458297
Treatments Being Tested
The goal of the study is to learn what happens to levels of digoxin in a he...
Status
Completed
Location
ICON (Site 0001)
Start Date
2023-11-07
Trial ID
NCT06625827
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability and to c...
Status
Recruiting
Location
Highlands Oncology Group ( Site 5405)
Start Date
2023-08-08
Trial ID
NCT05947851
Treatments Being Tested
The goal of this study is to evaluate nemtabrutinib compared with investiga...
Status
Recruiting
Location
USA Mitchell Cancer Institute ( Site 0014)
Start Date
2023-12-13
Trial ID
NCT06136559
Treatments Being Tested
The goal of the study is to learn what happens to levels of nemtabrutinib i...
Status
Completed
Location
Labcorp Clinical Research Unit Inc. (Site 0001)
Start Date
2023-10-02
Trial ID
NCT06772818
Treatments Being Tested